NARI - Inari Medical, Inc.
IEX Last Trade
53.605
9.215 17.191%
Share volume: 0
Last Updated: Tue 24 Dec 2024 06:18:42 PM CET
Surgical and Medical Instrument Manufacturing :
50.37%
PREVIOUS CLOSE
CHG
CHG%
$44.39
9.22
20.76%
Fundamental analysis
12%
Profitability
2%
Dept financing
13%
Liquidity
59%
Performance
10%
Performance
5 Days
-3.25%
1 Month
8.43%
3 Months
29.34%
6 Months
17.22%
1 Year
-18.35%
2 Year
-14.49%
Key data
Stock price
$53.60
DAY RANGE
$44.39 - $53.01
52 WEEK RANGE
$38.36 - $66.61
52 WEEK CHANGE
-$18.47
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/30/2024
Company detail
CEO: William H. Hoffman
Region: US
Website: inarimedical.com
Employees: 800
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Region: US
Website: inarimedical.com
Employees: 800
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Inari Medical, Inc. develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels. FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment.
Recent news